Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy of oral treatment with a
statin, SIMVASTATIN 40mg, in a target population of patients with severe chronic
rhinosinusitis resistant to surgery followed by conventional medical and surgical treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator:
Centre de Recherche du Centre Hospitalier de l'Université de Montréal